Literature DB >> 837483

Cryosurgical ablation of accessory atrioventricular connections: a method for correction of the pre-excitation syndrome.

J J Gallagher, W C Sealy, R W Anderson, J Kasell, R Millar, R W Campbell, L Harrison, E L Pritchett, A G Wallace.   

Abstract

Cryothermia, a new technique for definitive treatment of the pre-excitation syndrome, is described in two patients. The first patient presented with a normal P-R interval with a delta wave and reciprocating tachycardia. Preoperative electrophysiologic study suggested a free-wall atrioventricular connection on the left posterior atrioventricular (A-V) groove. At surgery, epicardial mapping confirmed the site of pre-excitation on the posterior left ventricular (LV) wall. An electrogram arising from the accessory pathway (AP) was recorded at the site of earliest ventricular activation. Interatrial delay combined with an apparently long accessory pathway to the ventricle caused the P-R interval to appear normal. Local pressure abolished pre-excitation. The site of early ventricular activation was cooled to -60 degrees C with a specially designed cryoprobe. All evidence of pre-excitation and arrhythmias disappeared. The second patient presented with a refractory reciprocating tachycardia and was found to have an AP in the septum capable of only retrograde conduction. Retrograde conduction was abolished by applying a temperature of 0 degrees C to the anulus at this site during tachycardia. Conduction over the AP and reciprocating tachycardia returned with rewarming. Ablation of the AP was obtained by applying a temperature of -60 degrees C for 90 seconds on two occasions to the same area. The His bundle was not injured.

Entities:  

Mesh:

Year:  1977        PMID: 837483     DOI: 10.1161/01.cir.55.3.471

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  16 in total

1.  Prediction of lesion size through monitoring the 0 degree C isothermic period following transcatheter cryoablation.

Authors:  A Hoekstra; C D de Langen; P G Nikkels; B J Korteling; K J Bel; H J Crijns
Journal:  J Interv Card Electrophysiol       Date:  1998-12       Impact factor: 1.900

Review 2.  Alternate energy sources for catheter ablation.

Authors:  P J Wang; M K Homoud; M S Link; N A Estes III
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

3.  Wolff-Parkinson-White syndrome: inadvertent permanent ablation of the accessory pathway during electrophysiological study.

Authors:  K Robinson; E Rowland; D M Krikler
Journal:  Br Heart J       Date:  1988-01

4.  Latent pre-excitation: exposure of anterograde accessory pathway conduction during atrial fibrillation.

Authors:  K Robinson; E Rowland; D M Krikler
Journal:  Br Heart J       Date:  1988-01

5.  A minimally invasive cox-maze procedure: operative technique and results.

Authors:  Anson M Lee; Kal Clark; Marci S Bailey; Abdulhameed Aziz; Richard B Schuessler; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2010 Jul-Aug

Review 6.  The histological effects of cryocoagulation on the myocardium and coronary arteries.

Authors:  S Iida; T Misaki; T Iwa
Journal:  Jpn J Surg       Date:  1989-05

7.  Electrophysiological manifestations of non-penetrating cardiac trauma.

Authors:  K M Fox; E Rowland; D M Krikler; H H Bentall; J F Goodwin
Journal:  Br Heart J       Date:  1980-04

8.  Exercise capacity and spontaneous heart rhythm after transvenous fulguration of atrioventricular conduction.

Authors:  P M Schofield; R J Bowes; N Brooks; D H Bennett
Journal:  Br Heart J       Date:  1986-10

9.  Cryoablation of the accessory pathway in Wolff-Parkinson-White syndrome: initial results and long term follow up.

Authors:  E Rowland; K Robinson; S Edmondson; D M Krikler; H H Bentall
Journal:  Br Heart J       Date:  1988-04

Review 10.  [High frequency current catheter ablation of accessory conduction pathways].

Authors:  G Hindricks; H Kottkamp; M Borggrefe; G Breithardt
Journal:  Herz       Date:  1998-06       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.